and a history of photocoagulation therapy for either proliferative retinopathy or CSME or anti-VEGF therapy. At DCCT closeout, the prevalences of these outcomes with CONV were 7–9% and were ...

Loss to follow-up was higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

India holds the unenviable position of being home to the world’s largest diabetic population, with nearly 100 million ...

The diabetic retinopathy progression outcome was defined ... anti-vascular endothelial growth factor injection, or panretinal photocoagulation. The authors noted limitations to their study ...

photocoagulation, laser treatment, and vitrectomy, depending upon the severity of the condition. When it comes to diabetic retinopathy, prevention is always the best option, especially since it ...

Although laser photocoagulation is an effective treatment for proliferative diabetic retinopathy, few options were available at that time for wet AMD (Box 1). Visual acuity tests are the most ...

Vasan Eye Care continues to pave the way for better vision and overall improved quality of life for everyone ...

Emergen Research Logo The development of anti-VEGF therapies, which inhibit the growth of abnormal blood vessels in the retina, reduces the ...

Retinopathy outcomes ... (SNPDR), and new proliferative diabetic retinopathy (PDR) among those without SNPDR or PDR, respectively, during the DCCT. Pan-retinal photocoagulation therapy was counted ...